ENTRY       D11931                      Drug
NAME        Inclisiran (USAN/INN);
            Leqvio (TN)
FORMULA     C529H707F12N176O316P43S6
EXACT_MASS  16331.1514
MOL_WEIGHT  16339.5061
CLASS       Hypolipidemic agent
             DG01946  Hypolipidemic agent
              DG03128  Anti-PCSK9 antibody and siRNA
REMARK      ATC code: C10AX16
            Chemical structure group: DG03216
            Product (DG03216): D12293<JP/US>
EFFICACY    Antihyperlipidemic, Translation inhibitor
  DISEASE   Heterozygous familial hypercholesterolemia [DS:H00155]
            Atherosclerotic cardiovascular disease [DS:H02505]
  TYPE      RNA interference (RNAi) drug
COMMENT     Treatment of hypercholesterolemia
TARGET      PCSK9 [HSA:255738] [KO:K13050]
  PATHWAY   hsa04979(255738)  Cholesterol metabolism
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C10 LIPID MODIFYING AGENTS
               C10A LIPID MODIFYING AGENTS, PLAIN
                C10AX Other lipid modifying agents
                 C10AX16 Inclisiran
                  D11931  Inclisiran (USAN/INN)
            Drug groups [BR:br08330]
             Hypolipidemic agent
              DG01946  Hypolipidemic agent
               DG03128  Anti-PCSK9 antibody and siRNA
                DG03216  Inclisiran
                 D11931  Inclisiran
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Serine peptidases
                PCSK9
                 D11931  Inclisiran (USAN/INN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11931
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11931
            Drug groups [BR:br08330]
             Hypolipidemic agent
              DG01946  Hypolipidemic agent
               DG03128  Anti-PCSK9 antibody and siRNA
                DG03216  Inclisiran
DBLINKS     CAS: 1639324-58-5
            ChEBI: 176399
///
